Literature DB >> 6507996

The effect of inhaled verapamil on resting bronchial tone and airway contractions induced by histamine and acetylcholine in normal and asthmatic subjects.

V T Popa, P Somani, V Simon.   

Abstract

In man, the influence of calcium entry blockers (CEB) on nonspecific bronchial sensitivity and resting bronchial tone is controversial. In 10 asthmatic and 8 normal subjects we recorded specific airway conductance (Gaw/VL) and flow volume loops before, 30, 60, and 90 min after the inhalation of saline, 10 (V10) and 20 mg (V20) of verapamil. The dose of inhaled histamine and acetylcholine producing Gaw/VL of -40% (PD40H and PD40ACH, respectively) with and without pretreatment with saline, V10, and, in 15 subjects, V20 was also determined. We measured plasma verapamil concentrations immediately after the end of nebulization of V10 and V20, and 30 and 60 min later. In normal subjects, V10 and V20 produced a maximal % delta Gaw/VL of 22.30 (+/- 19.50) and 33.00 (+/- 15.82), respectively (p less than 0.05). In asthmatics, V10 and V20 produced comparable % delta Gaw/VL of 22.00 (+/- 22.50) and 38.60 (+/- 38.60), respectively. This bronchodilating effect involved predominantly the large airways, persisted for 60 to 90 min, was reproducible, affected only some subjects (11 of 18), and was independent of the resting Gaw/VL, degree of bronchial sensitivity to H and ACH, and the time course of plasma verapamil concentration. The latter reached a maximum of 24.3 +/- 7.1 ng/ml after V20. In both normal and asthmatic subjects, saline or V10 did not significantly alter PD40H and PD40ACH. In normal subjects, pretreatment with V20 increased PD40H 5.3 times and PD40ACH 3.22 times (p less than 0.05). Except in 2 asthmatics, in whom V20 decreased PD40 and PD40ACH, it increased significantly PD40ACH (dose ratio: 3.15, p less than 0.05) but not PD40H.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6507996     DOI: 10.1164/arrd.1984.130.6.1006

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

2.  Inhalation of calcium channel blocking agents protects against methacholine-induced bronchoconstriction.

Authors:  T Tsuda; M Hatta; K Ishikawa; T Nakagawa; N Mabuchi; H Ando; O Nishida
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

3.  Possible Mechanisms for Functional Antagonistic Effect of Ferula assafoetida on Muscarinic Receptors in Tracheal Smooth Muscle.

Authors:  Majid Kiyanmehr; Mohammad Hossein Boskabady; Mohammad Reza Khazdair; Milad Hashemzehi
Journal:  Malays J Med Sci       Date:  2016-01

4.  Evaluation of antiasthmatic activity of ethanolic extract of Elephantopus scaber L. leaves.

Authors:  Rakesh Sagar; H B Sahoo
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

5.  Pharmacological evaluation of Apium leptophyllum (Pers.) on bronchial asthma.

Authors:  Himanshu Bhusan Sahoo; Rakesh Sagar; Ganesh Patro; Madhulita Panda; Saroj Kumar Sahoo; D Priyadarshini
Journal:  J Pharm Bioallied Sci       Date:  2016 Oct-Dec

6.  Relaxant effect of Curcuma longa on rat tracheal smooth muscle and its possible mechanisms.

Authors:  Bahman Emami; Farzaneh Shakeri; Vahideh Ghorani; Mohammad Hossein Boskabady
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

7.  Pharmacological effects of rosa damascena.

Authors:  Mohammad Hossein Boskabady; Mohammad Naser Shafei; Zahra Saberi; Somayeh Amini
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

8.  Calcium and potassium channels are involved in curcumin relaxant effect on tracheal smooth muscles.

Authors:  Bahman Emami; Farzaneh Shakeri; Zahra Gholamnezhad; Saeideh Saadat; Marzie Boskabady; Vahab Azmounfar; Hamed Sadatfaraji; Mohammad Hossein Boskabady
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

9.  Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections.

Authors:  Irene Rossi; Francesca Buttini; Fabio Sonvico; Filippo Affaticati; Francesco Martinelli; Giannamaria Annunziato; Diana Machado; Miguel Viveiros; Marco Pieroni; Ruggero Bettini
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.